This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schiffman, M. H. Articles by Sherman, M. E. Search for Related Content PubMed PubMed Citation Articles by Schiffman, M. H. Articles by Sherman, M. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 03 1995, 545-550, Vol 33, No. 3
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture

MH Schiffman, NB Kiviat, RD Burk, KV Shah, RW Daniel, R Lewis, J Kuypers, MM Manos, DR Scott and ME Sherman
Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Maryland, USA.

Epidemiologists and clinicians wishing to introduce human papillomavirus (HPV) testing into cervical cancer prevention programs need standardized, reliable, and accurate HPV DNA tests that can detect the full spectrum of pathogenic HPV types. The Hybrid Capture System assay from Digene (hybrid capture assay) is a nonradioactive kit designed to detect 14 HPV types in two groups: a mix of 9 high-risk types associated with anogenital cancer (HPV types 16, 18, 31, 33, 35, 45, 51, 52, and 56) and another group of 5 low-risk types associated with condyloma acuminatum (HPV types 6, 11, 42, 43, and 44). The assay yields quantitative data meant to reflect viral concentration. In a study of 199 cervical specimens from women with concurrent Pap smears, we assessed the reliability of the new assay by comparing the hybrid capture assay results from three laboratories. We assessed the accuracy of the hybrid capture assay in comparison with a reference standard of HPV DNA content (multiple testing by several methods in two reference laboratories). We also compared the hybrid capture assay results with the concurrent cytologic diagnoses on the basis of an independent review of each smear by five pathologists. Pairwise interlaboratory agreement rates on HPV positivity for either high-risk or low-risk types ranged from 87 to 94%, and kappa values ranged from 0.61 to 0.83. Among specimens positive for high-risk types (the most important clinical outcome), the interlaboratory correlations of the quantitative data ranged from 0.60 to 0.90.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

• Fontaine, J., Gravitt, P., Duh, L.-M., Lefevre, J., Pourreaux, K., Hankins, C., Coutlee, F., The Canadian Women's HIV Study Group, (2005). High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens. Cancer Epidemiol. Biomarkers Prev. 14: 2200-2207 [Abstract] [Full Text]  
• van Ham, M. A. P. C., Bakkers, J. M. J. E., Harbers, G. K., Quint, W. G. V., Massuger, L. F. A. G., Melchers, W. J. G. (2005). Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders. J. Clin. Microbiol. 43: 2662-2667 [Abstract] [Full Text]  
• Li, J., Gerhard, D. S., Zhang, Z., Huettner, P. C., Wright, J., Nguyen, L., Lu, D., Rader, J. S. (2003). Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus. J. Clin. Microbiol. 41: 5563-5571 [Abstract] [Full Text]  
• Kornegay, J. R., Roger, M., Davies, P. O., Shepard, A. P., Guerrero, N. A., Lloveras, B., Evans, D., Coutlee, F. (2003). International Proficiency Study of a Consensus L1 PCR Assay for the Detection and Typing of Human Papillomavirus DNA: Evaluation of Accuracy and Intralaboratory and Interlaboratory Agreement. J. Clin. Microbiol. 41: 1080-1086 [Abstract] [Full Text]  
• Mandelblatt, J. S., Lawrence, W. F., Gaffikin, L., Limpahayom, K. K., Lumbiganon, P., Warakamin, S., King, J., Yi, B., Ringers, P., Blumenthal, P. D. (2002). Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries. JNCI J Natl Cancer Inst 94: 1469-1483 [Abstract] [Full Text]  
• Mandelblatt, J. S., Lawrence, W. F., Womack, S. M., Jacobson, D., Yi, B., Hwang, Y.-t., Gold, K., Barter, J., Shah, K. (2002). Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer. JAMA 287: 2372-2381 [Abstract] [Full Text]  
• Cubie, H A, Seagar, A L, McGoogan, E, Whitehead, J, Brass, A, Arends, M J, Whitley, M W (2001). Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Mol. Pathol. 54: 24-29 [Abstract] [Full Text]  
• Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., Wacholder, S., Plummer, M., Schiffman, M. (2000). Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica. JNCI J Natl Cancer Inst 92: 464-474 [Abstract] [Full Text]  
• Nelson, J. H., Hawkins, G. A., Edlund, K., Evander, M., Kjellberg, L., Wadell, G., Dillner, J., Gerasimova, T., Coker, A. L., Pirisi, L., Petereit, D., Lambert, P. F. (2000). A Novel and Rapid PCR-Based Method for Genotyping Human Papillomaviruses in Clinical Samples. J. Clin. Microbiol. 38: 688-695 [Abstract] [Full Text]  
• Kónya, J., Veress, G., Juhász, A., Szarka, K., Sápy, T., Hernádi, Z., Gergely, L. (2000). Additional Human Papillomavirus Types Detected by the Hybrid Capture Tube Test among Samples from Women with Cytological and Colposcopical Atypia. J. Clin. Microbiol. 38: 408-411 [Abstract] [Full Text]  
• Giuliano, A. R., Papenfuss, M., Schneider, A., Nour, M., Hatch, K. (1999). Risk Factors for High-Risk Type Human Papillomavirus Infection among Mexican-American Women. Cancer Epidemiol. Biomarkers Prev. 8: 615-620 [Abstract] [Full Text]  
• Poljak, M., Brencic, A., Seme, K., Vince, A., Marin, I. J. (1999). Comparative Evaluation of First- and Second-Generation Digene Hybrid Capture Assays for Detection of Human Papillomaviruses Associated with High or Intermediate Risk for Cervical Cancer. J. Clin. Microbiol. 37: 796-797 [Abstract] [Full Text]  
• Peyton, C. L., Schiffman, M., Lörincz, A. T., Hunt, W. C., Mielzynska, I., Bratti, C., Eaton, S., Hildesheim, A., Morera, L. A., Rodriguez, A. C., Herrero, R., Sherman, M. E., Wheeler, C. M. (1998). Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies. J. Clin. Microbiol. 36: 3248-3254 [Abstract] [Full Text]  
• Lorincz, A., Tang, Y.-W., Persing, D. H. (1998). Hybrid Capture. Clin. Chem. 44: 1363-1363 [Full Text]